Navigation Links
Dey L.P. Settles State of Mississippi Pricing Litigation
Date:1/7/2009

NAPA, Calif., Jan. 7 /PRNewswire/ -- Dey, L.P. today announced that it has settled a lawsuit brought against it and other companies by the State of Mississippi in October 2005 pertaining to Medicaid reimbursements paid by the state to pharmacists and other healthcare providers. In exchange for a full release of claims, Dey has agreed to pay $3.8 million plus legal and other costs.

As part of the 2007 acquisition agreement between Mylan Inc. (Dey's parent company) and Merck KGaA (Dey's former parent company), Merck KGaA is responsible for paying the full amount of this settlement as well as all costs and other expenses associated with pending and future-related Medicaid reimbursement lawsuits involving Dey.

As part of the settlement, the state acknowledges that the settlement does not constitute admission or evidence of fault, liability or unlawful conduct by Dey.

Dey L.P., a subsidiary of Mylan Inc. (Nasdaq: MYL), is a specialty pharmaceutical company focused on the development, manufacturing and marketing of prescription drug products for the treatment of respiratory diseases, respiratory-related allergies and emergency care medicine. As the U.S. leader in sales of nebulized respiratory medication, Dey L.P. puts patients first through its development of innovative and affordable therapies. The Web sites for Dey L.P. include www.dey.com, www.accuneb.com, www.curosurfusa.com, www.cyanokit.com, www.duoneb.com, www.epipen.com and www.perforomist.com.


'/>"/>
SOURCE Dey, L.P.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Mylan Settles Its First-to-File Opportunity on Levetiracetam with UCB
2. Sunrise Settles Litigation Regarding Its 2007 Annual Meeting
3. Dr. William McGuire Settles with the SEC and the UnitedHealth Group Special Litigation Committee on Stock Options Matter
4. Novo Nordisk Settles With Pfizer On Patent Infringement Suit
5. Park Dental Doctor Group Settles Litigation With Service Provider
6. Dey, L.P. Settles State of Alabama Pricing Litigation
7. Breckenridge Pharmaceutical Settles Paragraph IV Litigation and Receives FDA Approval for its Oxcarbazepine ANDA
8. Walgreens Pays $35 Million, Settles Pharmacist-Whistleblower Qui Tam Drug Switching Allegations
9. US FDA Admits Risks of Mercury Dental Fillings, Settles Lawsuit
10. Bush Administration Settles Nationwide Class Action in Medicare Prescription Drug Case
11. Amerigroup Settles Federal and State Medicaid Fraud Claims for $225 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... Carlos ... problems. He has also continued to spiritually evolve, which is the purpose of everyone ... “ Our Spiritual Truths ” (published by Balboa Press) attempts to guide readers to ...
(Date:2/22/2017)... ... February 22, 2017 , ... Stem cell therapy has ... technology is so cutting edge, in fact, the U.S. Food and Drug Administration ... However, successful patient outcomes in certain clinical stem cell procedures have shown that ...
(Date:2/22/2017)... ... February 22, 2017 , ... South Bend’s Lunkerville, the award-winning TV ... feature Heroes On The Water (HOW), a non-profit organization dedicated to helping military veterans ... series host ‘Mike D’ traveling to Lake Denmark, New Jersey, to fish with war ...
(Date:2/22/2017)... Jacksonville, Fla. (PRWEB) , ... February 22, 2017 ... ... aneurysms is just as effective on smaller and sometimes harder to reach ones, ... findings were presented at the International Stroke Conference in Houston by Ricardo A. ...
(Date:2/22/2017)... Singapore, Singapore (PRWEB) , ... February 22, 2017 , ... ... high-end medical leads utilizing a simple online checklist. Over a period of just 24 ... with the assistance of an online checklist called T.A.D. , “The internet is not ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... NEW YORK , Feb. 22, 2017 /PRNewswire/ ... dominate medical implant demand, as aging demographic patterns ... heart-related conditions. Implants for sports- and exercise-related injuries, ... artery disease will lead sales gains. The future ... The study addresses the following questions and more: ...
(Date:2/23/2017)... Ill. , Feb. 23, 2017 Takeda ... subsidiary of Takeda Pharmaceutical Company Limited (TSE:4502) and Cognition ... PLC and Ctrl Group Limited, announced a collaboration to ... an Apple Watch wearable to monitor and assess cognitive ... Depression (MDD) is the leading cause of disability ...
(Date:2/23/2017)... 22, 2017 Mixed tocopherols market projected to grow ... market is projected to reach USD 5.27 billion by 2022, ... driven by factors such as health and wellness trends, for ... and regulations for sourcing, processing, packaging, and labeling of food ... markets such as the Asia-Pacific region ...
Breaking Medicine Technology: